On September 13, 2024, Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, celebrates 25 years of groundbreaking ...

Some of the world’s most influential scientists in cancer research gathered March 2-3 in Tampa for the inaugural “Microbes, Genes & Cancer” symposium. What matters is not only who attended, but what ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...

As the Trump administration makes major cuts to federal health agencies, including the National Institutes of Health, cancer patients and doctors are worried about stalls in research and medicine that ...

Improving Diagnosis and Care for Patients With Sarcoma: Do Real-World General Practitioners Data and Prospective Data Collections Have a Place Next to Clinical Trials? A thorough literature search was ...

Scientists have discovered how breast cancer cells can "hibernate" to avoid treatment and "wake up" years later—causing a relapse that is more difficult to treat. Their research, published in the ...

The National Biomarker Centre says the extra money will make a "huge difference" to its work.

Researchers have mapped the exact variants in a gene that dramatically increase a person's risk of developing several types of cancer. This could lead to improved early detection and targeted ...

America’s cancer research system, which has helped save millions of lives, is under threat in one of its most productive moments. Credit... Supported by By Jonathan Mahler Rachael Sirianni first ...

Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, biotechnology ...

Add Yahoo as a preferred source to see more of our stories on Google. A new triple-drug treatment for aggressive advanced breast cancer can cut deaths by a third, a major trial has found. The ...

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials National estimates of cancer ...